antisense oligonucleotide therapy (Chinook Therapeutics/Ionis Pharmaceuticals)

N/A

Report date: 2025/03/14 16:32:19
NME

Base Information

Drug Nameantisense oligonucleotide therapy (Chinook Therapeutics/Ionis Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionAntisense oligonucleotide inhibitors
TargetsUpdating
Therapy Area/IndicationsRenal Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesChinook Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesIonis Pharmaceuticals IncChinook Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsRenal Insufficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A